Forte Biosciences stockholders approve amended equity plan adding 3.34M shares

Forte Biosciences, Inc.

Stockholders approved A&R 2021 Equity Incentive Plan on Jan 24, 2025; 2.19M for, 0.47M against, 1.38M abstain.
Plan adds 3,340,000 shares to reserve plus up to 44,093 from forfeited prior plan awards.
Plan authorizes grants of options, SARs, restricted stock, RSUs, performance awards to employees, directors, consultants.
Plan prohibits Exchange Programs (no repricing or cancellation of underwater awards without shareholder approval).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.